MEF2C and amyotrophic lateral sclerosis: Similarly, MEF2C immunoreactivity level significantly decreased in lower motor neurons in the lumbar spinal cord of both ALS patients and the SOD1-G93A mouse model (Supplementary Fig. 2B, D).